SNS and PrEP Initiation and Adherence in Black SMM

September 13, 2023 updated by: DeMarc A. Hickson, PhD, Us Helping Us, People Into Living, Inc.

PrEP Initiation and Adherence Among Black SMM: A Social Network-Level Intervention

Specific Aim 1. Conduct 18 focus groups among Black gay, bisexual and other sexual minority men (SMM; n=72-90) in the Washington, DC area of different age groups (18-24, 25-34, 35+) and various pre-exposure prophylaxis (PrEP) use profiles (i.e., PrEP naïve, current PrEP users, and discontinued PrEP; two per age-group and PrEP use profile) to understand intervention feasibility, acceptability and appropriateness, how the intervention can address experienced and perceived socio-structural barriers, and increase PrEP initiation and adherence among Black SMM in the Washington, District of Columbia (DC) area.

Specific Aim 2. Implement an iterative open-phase pilot of an SNS intervention to increase PrEP initiation among human immunodeficiency virus (HIV)-negative Black SMM, aged 18 years and above, in the Washington, DC area. Recruit 30 PrEP-using Black SMM, including those who use substances, as Recruiters to identify and refer Network Associates to PrEP services. The pilot will occur in six blocks of up to 5 Recruiters to further develop all intervention procedures and enhance the social networking strategy (SNS) intervention's feasibility and acceptability.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The first 12 months (Phase 1: Formative Research) will be an intervention development/adaptation phase. Using a community-based participatory approach (n=18 age- and PrEP use profile-specific focus groups, of at least 4-5 participants each, totaling 72-90), participants will be asked about the social network dynamics and characteristics (e.g., influential network members, communication about PrEP as an HIV prevention method) that influenced their decision to initiate PrEP. Among participants with no PrEP use, they will be asked about the acceptability and feasibility of talking with PrEP-using Black SMM within their respective social network to support initiation along with preferences for relevant PrEP-related information from peers.

The following 12 months (Phase 2: Open-phase Pilot Study) will involve conducting an open pilot of the SNS intervention, in up to six batches of up to 5 participants (n=30), allowing for further intervention refinement. This will allow us to demonstrate participant feasibility and acceptance, which includes the ability to recruit network members, feasibility of intervention delivery, and changes in participant behaviors. It will allow for further evaluation of the feasibility of all study procedures, and refinement of intervention manual. Therefore, the expected outcome is a culturally relevant SNS intervention to increase PrEP initiation among Black SMM through PrEP-using social network members.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • District of Columbia
      • Washington, District of Columbia, United States, 20010-1646
        • Recruiting
        • Us Helping Us, People Into Living, Inc.
        • Contact:
        • Contact:
        • Principal Investigator:
          • DeMarc A Hickson, PhD
        • Sub-Investigator:
          • Adedotun Ogunbajo, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age of 18 years or above
  • Black or African American race
  • Cisgender male identity
  • Gay, bisexual or a male who has sex with other males
  • Residence in the greater Washington, DC area (includes District of Columbia, Prince George's County, MD and Montgomery County, MD)
  • Current PrEP use
  • Confirmed HIV-negative status.

Exclusion Criteria:

  • Being younger than 18 years of age ;
  • Cisgender or transgender female identity
  • Males having sex with women exclusively
  • Being unable to speak or read English
  • Reside outside of the defined greater Washington, DC area
  • Being unable or unwilling to provide written informed consent
  • Being unable to comply with the requirements of the protocol (e.g. persons with mental health conditions, persons who are intoxicated or incoherent for other reasons)
  • Being a member of other vulnerable populations: pregnant women, children or wards of the state.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: PrEP-using Black SMM as Recruiters
Recruit 30 PrEP-using Black SMM, including those who use substances, as Recruiters to identify and refer Network Associates to PrEP services. The pilot will occur in six blocks of up to 5 Recruiters to further develop all intervention procedures and enhance the SNS intervention's feasibility and acceptability.
Assess whether PrEP-using Black SMM can serve as an Interventionist to get their social and sexual network members to uptake and adhere to PrEP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of Intervention as measured by Weiner et al., 2017.
Time Frame: During the peer-based debriefing sessions that occurs before a Recruiter is dismissed from the open-phase pilot.
Assess the feasibility of intervention delivery method (i.e., PrEP-using SMM as the Interventionist/Recruiter).
During the peer-based debriefing sessions that occurs before a Recruiter is dismissed from the open-phase pilot.
Acceptability of Intervention as measured by Weiner et al., 2017.
Time Frame: During the peer-based debriefing sessions that occurs before a Recruiter is dismissed from the open-phase pilot.
Assess the feasibility of intervention delivery method (i.e., PrEP-using SMM as the Interventionist/Recruiter).
During the peer-based debriefing sessions that occurs before a Recruiter is dismissed from the open-phase pilot.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruited Network Members
Time Frame: Immediately after PrEP-using SMM enroll as an Interventionist (i.e., Recruiter)
Proportion of Recruiters who recruit Network Associates
Immediately after PrEP-using SMM enroll as an Interventionist (i.e., Recruiter)
Network members on PrEP
Time Frame: Immediately after PrEP-using SMM enroll as an Interventionist (i.e., Recruiter)
Number of Network Associates recruited
Immediately after PrEP-using SMM enroll as an Interventionist (i.e., Recruiter)
Comfortability of the Intervention as measured by an adaptation of Weiner et al., 2017.
Time Frame: During the peer-based debriefing sessions that occurs before a Recruiter is dismissed from the open-phase pilot.
Extent to which Network Associates were comfortable with the intervention modality
During the peer-based debriefing sessions that occurs before a Recruiter is dismissed from the open-phase pilot.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: DeMarc A Hickson, PhD, Executive Director

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Estimated)

December 1, 2023

Study Completion (Estimated)

December 1, 2023

Study Registration Dates

First Submitted

August 9, 2022

First Submitted That Met QC Criteria

August 11, 2022

First Posted (Actual)

August 12, 2022

Study Record Updates

Last Update Posted (Actual)

September 15, 2023

Last Update Submitted That Met QC Criteria

September 13, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 21-USHE-104

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV

Clinical Trials on Social Networking Strategies

3
Subscribe